Literature DB >> 7733399

Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver.

J Liao1, J A Keiser, W E Scales, S L Kunkel, M J Kluger.   

Abstract

A bidirectional communication exists between the nervous system and the immune system. Evidence has accumulated suggesting that cytokines-immune peptides influence sympathetic neuronal survival and that cytokines can promote the secretion of catecholamines. Using an isolated perfused rat liver (IPRL) preparation, we have shown that the liver is an important source of circulating cytokines in response to lipopolysaccharide (LPS) and that corticosterone dose dependently influenced LPS-induced production of tumor necrosis factor (TNF) and interleukin-6 (IL-6). In this study, we investigated the direct effect of epinephrine (another stress hormone) on the production of TNF and IL-6 in liver. We demonstrated that epinephrine (1 microM/ml) alone did not induce TNF bioactivity but significantly increased IL-6 bioactivity from IPRL effluent. When the IPRL was infused with LPS, epinephrine significantly decreased TNF bioactivity. Epinephrine in LPS-treated livers also significantly increased IL-6 bioactivity. Both responses were totally inhibited by the beta-blocker propranolol (10 microM/ml). Anisomycin, a protein synthesis inhibitor, infused into the IPRL completely blocked the rise in TNF and IL-6 concentrations in the effluent leaving the IPRL, supporting the hypothesis that the synthesis (or release) of these cytokines was dependent on protein synthesis. We then attempted to determine whether epinephrine exerts similar effects in vitro. Using isolated Kupffer cells and hepatocytes, we found that epinephrine alone had no effect on TNF and IL-6 production in Kupffer cells and hepatocytes but significantly decreased LPS-induced TNF bioactivity and increased LPS-induced IL-6 bioactivity in Kupffer cells. Our data support the hypothesis that epinephrine can promote IL-6 secretion from IPRL.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733399     DOI: 10.1152/ajpregu.1995.268.4.R896

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Does polycythemia affect interleukin-6 response pattern in early postnatal period?

Authors:  Arzu Akdag; Dilek Dilli; Omer Erdeve; Serife Suna Oğuz; Uğur Dilmen
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 2.  Glucocorticoids and central nervous system inflammation.

Authors:  Klaus Dinkel; William O Ogle; Robert M Sapolsky
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

3.  Adrenalectomy enhances response of tumour necrosis factor-alpha (TNF-alpha) to haemorrhage in the conscious rat.

Authors:  M Yamashita; M Yamashita
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

4.  Central injection of nitric oxide synthase inhibitors increases peripheral interleukin-6 and serum amyloid A: involvement of adrenaline from adrenal medulla.

Authors:  D K Song; Y B Im; J S Jung; J J Yan; S O Huh; H W Suh; Y H Kim
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 5.  Pathogenesis and therapeutic implications of cardiorenal syndrome.

Authors:  Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2010-11-23       Impact factor: 2.801

6.  Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans.

Authors:  R L Starkie; M J Arkinstall; I Koukoulas; J A Hawley; M A Febbraio
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

7.  Development and application of an isolated perfused rat liver model to study the stimulation and inhibition of tumor necrosis factor-alpha production ex vivo.

Authors:  Reza Mehvar; Xiaoping Zhang
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

Review 8.  Elucidating the unexplained underperformance syndrome in endurance athletes : the interleukin-6 hypothesis.

Authors:  Paula Robson
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 9.  Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects.

Authors:  Bente Klarlund Pedersen; Adam Steensberg; Pernille Keller; Charlotte Keller; Christian Fischer; Natalie Hiscock; Gerrit van Hall; Peter Plomgaard; Mark A Febbraio
Journal:  Pflugers Arch       Date:  2003-02-18       Impact factor: 3.657

10.  Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia.

Authors:  T van der Poll; S M Coyle; K Barbosa; C C Braxton; S F Lowry
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.